Disease Mongering and Pharma Credibility

Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.

We accept advertising relevant to the interests of our members.
For more information, see:

Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com

My Humble Opinion	Other People's Opinion
A "Must Read" Blog for Insiders. -- Wall Street Journal	A bi-weekly podcast. Listen and call-in live online or download to your iPod!

| Also see Pharma Marketing News OpEd Pieces |

Disease Mongering and Pharma Credibility

Posted: January 25, 2007

This past Tuesday, Neil H. Gray, Managing Partner, Healthcare Trends & Strategies, LLC, and I put together a "Point-Counterpoint" debate on the issues related to disease mongering and pharma credibility at the Patient Education and Disease Awareness Summit in Philadelphia. Neil and I have discussed this topic before in a Pharma Marketing Talk podcast, which you can listen to here.

For the Summit audience, we decided to take opposite sides to debate several questions, including:

Is it a real issue?
Lack of blockbuster drugs in pipeline a factor?
Influence of DTC advertising
Impact on pharma credibility

Disease mongering may be just one more nail in the coffin of pharma credibility.

Read more about this, including some data from a recent PwC Survey and a video showcasing a new medical condition, in today's post to Pharma Marketing Blog.

Disease Mongering -- Is it real or not?

After reading about it, please let me know your opinioon by posting comments here in this forum or by taking the "Is it Real or not?" online survey. Thanks!

For more posts in related topic areas, see:

If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.

| Return to Pharma Marketing Blog Topics |

Special Supplement
ePharma Marketing

Many experts believe that pharma eMarketing is at a tipping point and that pharmaceutical companies are poised to shift substantial ad spending from TV and other media to the Internet.

The selection of articles in this Special Supplement to Pharma Marketing News was chosen to give you a better perspective on pharma eMarketing. Included are real world case studies that illustrate the advantages of eMarketing such as depth of information, interaction, relationship building and superior customer engagement.

TABLE OF CONTENTS

Order and pay for this Special Supplement now using your credit card

ONLY $29.95
PDF file delivered to you by email (usually within minutes of placing your order):

Special Supplement
Relationship Marketing

Direct, Targeted, Permission-based Marketing Builds Relationships, Increases ROI and Improves Patient Compliance

This collection of Pharma Marketing News articles, blog posts, and survey results provides you with an excellent introduction to the many facets and uses of pharmaceutical relationship marketing.

TABLE OF CONTENTS

Order and pay for this Special Supplement now using your credit card

ONLY $29.95
PDF file delivered to you by email (usually within minutes of placing your order):

If you wish to be pay by check or credit card off-line, please use:
Printable Order Form